Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Depreciation and Depletion (2016 - 2026)

Ovid Therapeutics filings provide 11 years of Depreciation and Depletion readings, the most recent being $35000.0 for Q1 2026.

  • Quarterly Depreciation and Depletion fell 59.77% to $35000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $148000.0 through Mar 2026, down 61.66% year-over-year, with the annual reading at $200000.0 for FY2025, 50.0% down from the prior year.
  • Depreciation and Depletion hit $35000.0 in Q1 2026 for Ovid Therapeutics, roughly flat from $35000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $131632.0 in Q4 2022 and bottomed at $17000.0 in Q3 2025.
  • Average Depreciation and Depletion over 5 years is $79598.4, with a median of $91000.0 recorded in 2024.
  • The largest annual shift saw Depreciation and Depletion soared 518.72% in 2022 before it tumbled 83.81% in 2025.
  • Ovid Therapeutics' Depreciation and Depletion stood at $131632.0 in 2022, then crashed by 37.71% to $82000.0 in 2023, then rose by 10.98% to $91000.0 in 2024, then tumbled by 61.54% to $35000.0 in 2025, then changed by 0.0% to $35000.0 in 2026.
  • Per Business Quant, the three most recent readings for OVID's Depreciation and Depletion are $35000.0 (Q1 2026), $35000.0 (Q4 2025), and $17000.0 (Q3 2025).